Page last updated: 2024-09-05

sorafenib and 2,5-dimethylcelecoxib

sorafenib has been researched along with 2,5-dimethylcelecoxib in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (2,5-dimethylcelecoxib)	Trials (2,5-dimethylcelecoxib)	Recent Studies (post-2010) (2,5-dimethylcelecoxib)
6,520	730	5,251	42	0	28

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Y; Chen, Z; Pan, B; Qiu, J; Tang, N; Wang, X	1

Other Studies

1 other study(ies) available for sorafenib and 2,5-dimethylcelecoxib

Article	Year
Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPK. Toxicology in vitro : an international journal published in association with BIBRA, 2021, Volume: 76 Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytochrome P-450 CYP3A; Drug Interactions; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Sorafenib; Sulfonamides	2021

Article

Year

Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPK.

Toxicology in vitro : an international journal published in association with BIBRA, 2021, Volume: 76

Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytochrome P-450 CYP3A; Drug Interactions; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Sorafenib; Sulfonamides

2021